phenolic monomer on peroxidase-catalyzed o-methoxyphenol
oxidation. To that end, we studied the oxidation of vanillin
the side chain. An obvious difference lies in the electron-
donating/withdrawing character of the para substituent.
4-Methylguaiacol has an electron-donating substituent and
leads to relatively simple dimers, trimers, and higher oligo-
mers. Apocynin and vanillin contain electron-withdrawing
para substituents, which appear to favor quinone formation
and demethylation. We and others have performed Hammett
(4-hydroxy-3-methoxybenzaldehyde) and 4-methylguaicol.
Reactions were performed under conditions identical to those
used for apocynin at pH 6-8. As summarized in Table 1,
vanillin yielded a product spectrum that was significantly
distinct from that obtained from apocynin. At all three pHs,
vanillin underwent oxidation to predominantly quinone
products with minimal hydroxylation. Unlike apocynin,
significant ortho demethylation was observed (anywhere
from 53-72% of the converted vanillin was oxidized to a
demethylated product), such that at pH 6, ca. 50% of the
vanillin oxidation products was a didemethylated tetrameric
quinone (IVQ-2Me).
2
8,29
analysis of peroxidase catalysis.
In aqueous solutions,
the Hammett coefficient is negative, indicating increased
enzyme activity on electron-donating para substituents. Most
of these substrates undergo ortho-ortho coupling to give
simple oligomers and polymers. The less reactive electron-
withdrawing substituents also undergo oligomerization; how-
ever, their slower oxidation rate may favor noncoupling
reactions such as demethylation, hydroxylation, and oxidation
to quinones (mainly 1,4-quinones, but 1,2-quinones are
possible following demethylation).
In contrast, the major products from the oxidation of
4-methylguaiacol, which bears an electron-donating side
chain, were simple oligomers (dimer II and trimer III) with
relatively little influence of reaction pH (Figure 1).
Further work is needed to elucidate the precise mechanism
of product formation. In any event, the uniqueness of the
o-methoxy group is highlighted by using the apocynin
analogue 4-hydroxy-3-methylacetophenone. This compound,
which was poorly reactive (98% of the starting material was
recovered unchanged), formed primarily the dimer and did
3
0
not produce a complex mixture of oligomers.
In summary, peroxidase catalyzes the oxidation of o-meth-
oxyphenols to a wide array of oligomeric products, including
demethylated, quinones, and demethylated quinones. This
structural richness appears to be promoted by electron-with-
drawing substituents in the para position. The combination
of the two has served nature well as a common structural
motif for a range of biologically important compounds, in-
cluding some with therapeutic potential.
Acknowledgment. This work was supported by the
National Institutes of Health (GM66712). The authors are
grateful to Dr. Dmitri Zagorevski for his help with the mass
spectrometer (Grant CHE 0091892).
Figure 1. Final percentage of the total product of dimer, trimer,
tetramer, and pentamer as a function of the substrate (4-meth-
ylguaiacol, apocynin, vanillin).
Note Added after ASAP. One author name, Lakshmi
Santhanam, was missing in the version posted ASAP May
7
, 2004; the corrected version was posted May 13, 2004.
The different product spectra obtained from these three
closely related peroxidase substrates is due to the nature of
Supporting Information Available: Detailed general
procedure for SBP-catalyzed oxidation of phenols, full MS
data for compounds given in Table 1, and spectral data of
selected compounds. This material is available free of charge
via the Internet at http://pubs.acs.org.
(
18) Liu, W.; Cholli, A. L.; Nagarajan, R.; Kumar, J.; Tripathy, S.; Bruno,
F. F.; Samuelson, L. J. Am. Chem. Soc. 1999, 121, 11345-11355.
19) Reihmann, M. H.; Ritter, H. Macromol. Chem. Phys. 2000, 201,
593-1597.
20) Dordick, J. S.; Klibanov, A. M.; Marletta, M. A. Biochemistry 1986,
5, 2946-2951.
21) Durliat, H.; Courteix, A.; Comtat, M.; Seris, J. L. J. Mol. Catal.
992, 75, 357-369
22) Kazandjian, R. Z.; Klibanov, A. M. J. Am. Chem. Soc. 1985, 107,
(
1
2
1
5
(
OL049448L
(
(26) Boots, A. W.; Kubben, N.; Haenen, G. R. M. M.; Bast, A. Biochem.
Bioph. Res. Co. 2003, 308, 560-565.
(
448-5450.
(27) Eastmond, D. A.; Smith, M. T.; Ruzo, L. O.; Ross, D. Mol.
Pharmacol. 1986, 30, 674-679.
(
23) Meunier, G.; Meunier, B. J. Am. Chem. Soc. 1985, 107, 2558-2560.
(24) Arnone, A.; Merlini, L.; Mondelli, R.; Nasini, G.; Ragg, E.;
(28) Dunford, H. B.; Adeniran, A. J. Arch. Biochem. Biophys. 1986, 251,
536-42.
Scaglioni, L.; Weiss, U. J. Chem. Soc., Perkin Trans. 2 1993, 1447-1454.
25) Awad, H. M.; Boersma, M., G.; Boeren, S.; van Bladeren, P. J.;
Vervoort, J.; Rietjens, I. M. C. M. Chem. Res. Toxicol. 2001, 14, 398-408
(
(29) Ryu, K.; Dordick, J. S. Biochemistry 1992, 31, 2588-2598.
(30) See Supporting Information for details.
1978
Org. Lett., Vol. 6, No. 12, 2004